glp-1 agonists drug class Table 1 from Glucagon-Like Peptide-1 (GLP-1) Receptor Review GLP-1 Agonists - What is

These findings provide a mechanistic basis for the hypothesis that GLP-1 agonists could help curb addictive behaviors in humans

Cancers (Basel), 13 , 135

GBD 2015 Risk Factors Collaborators

both produce large, clinically meaningful weight loss in human trials

Patients commonly report reduced hunger, earlier satiety, decreased cravings for high-calorie foods, and sometimes complete food indifference

These findings provide comprehensive information to move into Phase 3 development and reinforce alenigliprons potential to become a backbone oral small molecule therapy for obesityone that is accessible, scalable, and combinable